biote Corp. (BTMD)
| Market Cap | 83.85M |
| Revenue (ttm) | 192.22M |
| Net Income (ttm) | 27.05M |
| Shares Out | 37.27M |
| EPS (ttm) | 0.74 |
| PE Ratio | 3.04 |
| Forward PE | 9.78 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 108,763 |
| Open | 2.190 |
| Previous Close | 2.270 |
| Day's Range | 2.190 - 2.280 |
| 52-Week Range | 1.270 - 4.750 |
| Beta | 1.29 |
| Analysts | Strong Buy |
| Price Target | 2.83 (+25.78%) |
| Earnings Date | May 6, 2026 |
About BTMD
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice m... [Read more]
Financial Performance
In 2025, biote's revenue was $192.22 million, a decrease of -2.52% compared to the previous year's $197.19 million. Earnings were $27.05 million, an increase of 756.67%.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for BTMD stock is "Strong Buy." The 12-month stock price target is $2.83, which is an increase of 25.78% from the latest price.
News
Biote Schedules First Quarter 2026 Financial Results Release and Conference Call
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practi...
SunTx Capital Partners' Portfolio Company, Suncrete, and Haymaker Acquisition Corp. 4, Successfully Complete Business Combination
Combined Company to Trade as Suncrete Under Ticker "RMIX" Suncrete to Ring the Nasdaq Stock Market Closing Bell DALLAS, April 8, 2026 /PRNewswire/ -- Concrete Partners Holding, LLC ("CPH"), a ready-m...
Suncrete and Haymaker Acquisition Corp. 4 Announce Upsizing of Private Placement from $105.5 Million to $167.1 Million and Extend Stockholder Redemption Deadline
DALLAS, March 27, 2026 /PRNewswire/ -- Concrete Partners Holding, LLC ("Suncrete" or the "Company"), a ready-mix concrete logistics and distribution platform strategically located in Oklahoma and Arka...
Suncrete and Haymaker Acquisition Corp. 4 Announce Entering Into Non-Redemption Agreements with Certain Institutional Investors
DALLAS, March 25, 2026 /PRNewswire/ -- Concrete Partners Holding, LLC ("Suncrete" or the "Company"), a ready-mix concrete logistics and distribution platform strategically located in Oklahoma and Arka...
biote Earnings Call Transcript: Q4 2025
Revenue declined in Q4 2025 due to higher clinic attrition and a voluntary recall, but dietary supplement sales grew strongly. Investments in sales and technology are expected to drive a return to procedure revenue growth in the second half of 2026, with full-year revenue forecast above $190M.
Biote Reports Fourth Quarter and Full Year 2025 Financial Results
IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announce...
Suncrete Announces Support Agreements with a Majority of Warrantholders
DALLAS, March 4, 2026 /PRNewswire/ -- Concrete Partners Holding, LLC ("Suncrete" or the "Company"), a ready-mix concrete logistics and distribution platform strategically located in Oklahoma and Arkan...
Biote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference Call
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading innovator advancing the healthspan of patients' lives by providing hormone replacement therapy and heal...
biote Earnings Call Transcript: Q3 2025
Q3 2025 revenue declined 6.7% year-over-year, with procedure revenue down 10.4% and dietary supplements up 8.4%. Gross margin improved, but adjusted EBITDA fell 20.5%. Strategic initiatives and sales force ramp-up are expected to drive future growth.
Biote Reports Third Quarter 2025 Financial Results
IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announce...
Biote Schedules Third Quarter 2025 Financial Results Release and Conference Call
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...
Suncrete Completes Oklahoma Acquisition
Company Enters Oklahoma City Metro Area with 20 Plants DALLAS , Oct. 21, 2025 /PRNewswire/ -- Concrete Partners Holding, LLC (d.b.a. Suncrete), a ready-mix concrete logistics and distribution platform...
SunTx Capital Partners' Portfolio Company, Suncrete, to Pursue Listing on the New York Stock Exchange through a Proposed Business Combination with Haymaker Acquisition Corp. 4
DALLAS and NEW YORK , Oct. 9, 2025 /PRNewswire/ -- SunTx Capital Partners ("SunTx"), a leading Texas-based private equity firm that invests in construction materials, manufacturing, distribution and s...
biote Earnings Call Transcript: Q2 2025
Q2 2025 saw flat revenue as procedure sales declined but dietary supplements grew over 30%. Organizational restructuring and new sales strategies are underway, with 2025 guidance set above $190M revenue and $50M adjusted EBITDA. Cash flow remains strong despite share repurchases.
Biote Reports Second Quarter 2025 Financial Results
IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today a...
Biote Schedules Second Quarter 2025 Financial Results Release and Conference Call
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...
Biote Names Rich Barrera to Board of Directors
IRVING, Texas--(BUSINESS WIRE)--biote Corp.(NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, to...
biote Earnings Call Transcript: Q1 2025
Revenue grew 4.7% year-over-year to $49.0 million, with dietary supplements up 25.5% and procedure revenue down 3.6%. Gross margin improved to 74.3%. Strategic restructuring aims to accelerate growth, with 2025 guidance reaffirmed and a one-time restructuring charge expected.
Biote Reports First Quarter 2025 Financial Results
IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today a...
Biote Schedules First Quarter 2025 Financial Results Release and Conference Call
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...
Biote Announces Purchase of Shares by Directors and CEO
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”) a leading solutions provider in preventive health care through the delivery of personalized hormone optimization a...
biote Earnings Call Transcript: Q4 2024
Q4 revenue grew 9% year-over-year to $49.8M, with gross margin up to 71.8% and adjusted EBITDA rising 11.4%. 2025 guidance projects revenue of $202–$208M and adjusted EBITDA of $59–$64M, with growth driven by new practitioner onboarding and expanded product offerings.
Biote Reports Fourth Quarter and Full Year 2024 Financial Results
IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today a...
Biote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference Call
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...
Biote Announces CEO Retirement and Succession Plan
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (NASDAQ: BTMD) (“Biote” or the “Company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization ...